Schiller GJ - Search Results

1

Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemia.

Roboz GJ, Larson ML, Rubenstein SE, Solomon SR, Schiller GJ, An Q, Chiarella M, Louie AC, Lin TL. Roboz GJ, et al. Among authors: schiller gj. Leuk Lymphoma. 2020 May;61(5):1188-1194. doi: 10.1080/10428194.2020.1725503. Epub 2020 Feb 26. Leuk Lymphoma. 2020. PMID: 32102577

2

Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Territo M, Nimer S, Lee M, Belin T, Champlin R. Schiller G, et al. Blood. 1992 Dec 15;80(12):2977-82. Blood. 1992. PMID: 1467513 Free article. Clinical Trial.

3

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia.

Schiller G, Gajewski J, Nimer S, Territo M, Ho W, Lee M, Champlin R. Schiller G, et al. Br J Haematol. 1992 Jun;81(2):170-7. doi: 10.1111/j.1365-2141.1992.tb08203.x. Br J Haematol. 1992. PMID: 1643014 Clinical Trial.

4

Postremission chemotherapy for adults with acute myelogenous leukemia: improved survival with high-dose cytarabine and daunorubicin consolidation treatment.

Champlin R, Gajewski J, Nimer S, Vollset S, Landaw E, Winston D, Schiller G, Ho W. Champlin R, et al. J Clin Oncol. 1990 Jul;8(7):1199-206. doi: 10.1200/JCO.1990.8.7.1199. J Clin Oncol. 1990. PMID: 1694236 Clinical Trial.

5

Bone marrow transplantation versus high-dose cytarabine-based consolidation chemotherapy for acute myelogenous leukemia in first remission.

Schiller GJ, Nimer SD, Territo MC, Ho WG, Champlin RE, Gajewski JL. Schiller GJ, et al. J Clin Oncol. 1992 Jan;10(1):41-6. doi: 10.1200/JCO.1992.10.1.41. J Clin Oncol. 1992. PMID: 1727924

6

Treatment of resistant acute myeloid leukemia.

Schiller G. Schiller G. Blood Rev. 1991 Dec;5(4):220-6. doi: 10.1016/0268-960x(91)90012-2. Blood Rev. 1991. PMID: 1782481 Review.

7

Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.

Schiller G, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Leuk Lymphoma. 1994 Sep;15(1-2):85-90. doi: 10.3109/10428199409051682. Leuk Lymphoma. 1994. PMID: 7858506

8

Effect of induction cytarabine dose intensity on long-term survival in acute myelogenous leukemia: results of a randomized, controlled study.

Schiller G, Nimer S, Gajewski J, Lee M, Ho W, Territo M, Champlin R. Schiller G, et al. Leuk Lymphoma. 1993 Sep;11(1-2):69-77. doi: 10.3109/10428199309054732. Leuk Lymphoma. 1993. PMID: 8220156 Clinical Trial.

9

Postremission therapy of acute myeloid leukemia in older adults.

Schiller GJ. Schiller GJ. Leukemia. 1996 Apr;10 Suppl 1:S18-20. Leukemia. 1996. PMID: 8618463 Review.

10

High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia.

Schiller G, Emmanoulides C, Iastrebner MC, Lee M, Naeim F. Schiller G, et al. Leuk Lymphoma. 1996 Feb;20(5-6):427-34. doi: 10.3109/10428199609052424. Leuk Lymphoma. 1996. PMID: 8833398 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

248 results

Search Page

Filters